Building bridges between drug development and cancer science: a tribute to José Baselga's legacy

Ann Oncol. 2021 Jul;32(7):825-828. doi: 10.1016/j.annonc.2021.03.209. Epub 2021 Apr 7.

Authors

D M Hyman¹, J-C Soria², J Tabernero³

Affiliations

¹ Loxo Oncology and Eli Lilly, Stamford, USA. Electronic address: [email protected].
² Institut Gustave Roussy, Paris, France; Paris-Saclay University, Orsay, France.
³ Vall d'Hebron Institute of Oncology, Barcelona, Spain.

PMID: 33838220
DOI: 10.1016/j.annonc.2021.03.209

No abstract available

Publication types

Biography
Editorial
Historical Article

MeSH terms

Drug Development
History, 20th Century
Humans
Medicine*
Neoplasms* / drug therapy

Personal name as subject

José Baselga